JP7013419B2 - 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌 - Google Patents

炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌 Download PDF

Info

Publication number
JP7013419B2
JP7013419B2 JP2019145173A JP2019145173A JP7013419B2 JP 7013419 B2 JP7013419 B2 JP 7013419B2 JP 2019145173 A JP2019145173 A JP 2019145173A JP 2019145173 A JP2019145173 A JP 2019145173A JP 7013419 B2 JP7013419 B2 JP 7013419B2
Authority
JP
Japan
Prior art keywords
inflammatory cytokine
production
inducing activity
strain
cytokine production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019145173A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021023231A (ja
JP2021023231A5 (https=
Inventor
洋介 砂田
明美 伊木
和也 上原
勇介 谷井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissin Foods Holdings Co Ltd
Original Assignee
Nissin Foods Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2019145173A priority Critical patent/JP7013419B2/ja
Application filed by Nissin Foods Holdings Co Ltd filed Critical Nissin Foods Holdings Co Ltd
Priority to PCT/JP2020/029299 priority patent/WO2021024915A1/ja
Priority to EP20850115.5A priority patent/EP4011216A4/en
Priority to KR1020217036918A priority patent/KR20220038588A/ko
Priority to CN202080022843.5A priority patent/CN113597467A/zh
Priority to TW109126409A priority patent/TW202115104A/zh
Publication of JP2021023231A publication Critical patent/JP2021023231A/ja
Publication of JP2021023231A5 publication Critical patent/JP2021023231A5/ja
Application granted granted Critical
Publication of JP7013419B2 publication Critical patent/JP7013419B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2019145173A 2019-08-07 2019-08-07 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌 Active JP7013419B2 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2019145173A JP7013419B2 (ja) 2019-08-07 2019-08-07 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
EP20850115.5A EP4011216A4 (en) 2019-08-07 2020-07-30 BIFIDOBACTERIUM HAVING LOW INFLAMMATORY CYTOKINE GENERATION INDUCING ACTIVITY AND HIGH ANTI-INFLAMMATORY CYTOKINE GENERATION INDUCING ACTIVITY
KR1020217036918A KR20220038588A (ko) 2019-08-07 2020-07-30 염증성 사이토카인의 산생 유도 활성은 낮지만 항염증성 사이토카인의 산생 유도 활성이 높은 비피더스균
CN202080022843.5A CN113597467A (zh) 2019-08-07 2020-07-30 具有诱导炎症性细胞因子产生的低活性但诱导抗炎性细胞因子产生的高活性的双歧杆菌
PCT/JP2020/029299 WO2021024915A1 (ja) 2019-08-07 2020-07-30 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
TW109126409A TW202115104A (zh) 2019-08-07 2020-08-05 發炎性細胞介素之產生誘導活性低但抗發炎性細胞介素之產生誘導活性高的雙叉乳酸桿菌

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019145173A JP7013419B2 (ja) 2019-08-07 2019-08-07 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌

Publications (3)

Publication Number Publication Date
JP2021023231A JP2021023231A (ja) 2021-02-22
JP2021023231A5 JP2021023231A5 (https=) 2021-11-11
JP7013419B2 true JP7013419B2 (ja) 2022-02-15

Family

ID=74504115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019145173A Active JP7013419B2 (ja) 2019-08-07 2019-08-07 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌

Country Status (6)

Country Link
EP (1) EP4011216A4 (https=)
JP (1) JP7013419B2 (https=)
KR (1) KR20220038588A (https=)
CN (1) CN113597467A (https=)
TW (1) TW202115104A (https=)
WO (1) WO2021024915A1 (https=)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521537A (ja) 2003-04-01 2006-09-21 ザ プロクター アンド ギャンブル カンパニー 腸の炎症性疾患の治療の有効性を決定する方法
WO2012014971A1 (ja) 2010-07-30 2012-02-02 株式会社明治 メタボリックシンドローム改善効果を有する乳酸菌
US20120064118A1 (en) 2009-03-05 2012-03-15 Probiotical S.P.A. Bacteria strains having a high anti-inflammatory activity
JP2012526528A (ja) 2009-05-11 2012-11-01 ネステク ソシエテ アノニム 乳幼児及び若年小児のためのプロバイオティクスを含む乳幼児及び若年小児用補給調製乳
JP2013509204A (ja) 2009-11-11 2013-03-14 アリメンタリー、ヘルス、リミテッド ビフィズス菌株
US20130224253A1 (en) 2010-11-11 2013-08-29 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
US20130224167A1 (en) 2010-11-11 2013-08-29 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections to reduce absence from school or daycare
US20170252382A1 (en) 2014-08-29 2017-09-07 Chr. Hansen A/S Probiotic bifidobacterium adolescentis strains

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4589618B2 (ja) 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 免疫調節性機能を誘導する乳酸菌類とその成分
JP5019961B2 (ja) * 2006-06-26 2012-09-05 株式会社ヤクルト本社 インターロイキン１０産生促進剤
MX356598B (es) * 2008-11-11 2018-06-04 Alimentary Health Ltd Bifidobacterium longum.
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006521537A (ja) 2003-04-01 2006-09-21 ザ プロクター アンド ギャンブル カンパニー 腸の炎症性疾患の治療の有効性を決定する方法
US20120064118A1 (en) 2009-03-05 2012-03-15 Probiotical S.P.A. Bacteria strains having a high anti-inflammatory activity
JP2012526528A (ja) 2009-05-11 2012-11-01 ネステク ソシエテ アノニム 乳幼児及び若年小児のためのプロバイオティクスを含む乳幼児及び若年小児用補給調製乳
JP2013509204A (ja) 2009-11-11 2013-03-14 アリメンタリー、ヘルス、リミテッド ビフィズス菌株
WO2012014971A1 (ja) 2010-07-30 2012-02-02 株式会社明治 メタボリックシンドローム改善効果を有する乳酸菌
US20130224253A1 (en) 2010-11-11 2013-08-29 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
US20130224167A1 (en) 2010-11-11 2013-08-29 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections to reduce absence from school or daycare
US20170252382A1 (en) 2014-08-29 2017-09-07 Chr. Hansen A/S Probiotic bifidobacterium adolescentis strains

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GAD,Monika et al.，Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteria，FEMS Immunol Med Microbiol，2011年，vol.63，p.93-107

Also Published As

Publication number Publication date
JP2021023231A (ja) 2021-02-22
EP4011216A4 (en) 2023-08-16
TW202115104A (zh) 2021-04-16
KR20220038588A (ko) 2022-03-29
WO2021024915A1 (ja) 2021-02-11
EP4011216A1 (en) 2022-06-15
CN113597467A (zh) 2021-11-02

Similar Documents

Publication Publication Date Title
Homayouni-Rad et al. Kluyveromyces marxianus as a probiotic yeast: A mini-review
JP5527690B2 (ja) 免疫調節性機能誘導剤及び食品組成物
KR20090024175A (ko) 면역조절 활성이 높은 유산균의 배양법
JP6495869B2 (ja) ヒアルロン酸産生促進能を有する乳酸菌
JP2007070249A (ja) 免疫機能調節剤、抗アレルギー剤、免疫調節用組成物及び抗アレルギー用組成物並びにこれらが含まれた食品
US7501274B2 (en) Lactic acid bacteria with immunoregulating activities
JP4891255B2 (ja) ワイン発酵もろみ由来の免疫調節作用を有する乳酸菌
AU2005247215B2 (en) A composition having immunoregulating activities comprising Lactobacillus pentosus
KR102155849B1 (ko) 유해 미생물에 대한 항균 활성과 유산 생성능을 갖는 락토바실러스 플란타룸 srcm102369 균주 및 이의 용도
JP2009256312A (ja) 免疫調節用組成物およびそれを用いた飲食品または飲食品素材
JP7684029B2 (ja) 発毛・育毛効果を有する乳酸菌
JP6345642B2 (ja) 新規乳酸菌
JP7013419B2 (ja) 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
JP2022071985A (ja) Ｉｇｆ－１の産生を促進するビフィドバクテリウム属に属するビフィズス菌。
WO2022050302A1 (ja) Ｉｌ－１７の産生を抑制するビフィズス菌
JP2021164435A (ja) ビフィズス菌増殖促進剤
HK40060714A (en) Bifidobacteria having low activity of inducing inflammatory cytokine production but high activity of inducing anti-inflammatory cytokine production
JP2018113892A (ja) 抗炎症性サイトカイン産生誘導能力を有するビフィズス菌
JP2009254236A (ja) 新規乳酸菌並びに新規乳酸菌を利用した飲食品及び免疫賦活剤
JP2022117889A (ja) 酸化ストレス抵抗性付与能（ｉｌ－８抑制能）及び小腸幹細胞遺伝子調節機能を有する乳酸菌
HK40081085B (zh) 抑制il-17的产生的双歧杆菌
JP5851242B2 (ja) チオレドキシン誘導活性を有する乳酸菌ならびにチオレドキシンを介する生体傷害の予防および／または改善用の飲食品および医薬品

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210929

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210929

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20210930

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211224

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220118

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220119

R150 Certificate of patent or registration of utility model

Ref document number: 7013419

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250